Shire plc Press Releases

SHPG 
$147.36
*  
0.58
 negative 
0.4%
Get SHPG Alerts
*Delayed - data as of Apr. 17, 2014 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Genocea Appoints Jonathan Poole as Chief Financial Officer
4/7/2014 9:00:00 AM - Business Wire

Shire Pharmaceuticals Initiates Voluntary Nationwide Recall Of One batch, Packaged into Three Lots of VPRIV® (velaglucerase alfa for injection)
3/14/2014 12:00:00 PM - PR Newswire

Shire to Present at the Cowen and Company 34th Annual Health Care Conference
3/4/2014 7:00:00 AM - PR Newswire

Shire Recognizes Rare Disease Day 2014
2/28/2014 2:00:00 AM - PR Newswire

ViroPharma Announces Results of Tender Offer for its 2.00% Convertible Senior Notes Due 2017
2/25/2014 7:10:00 AM - PR Newswire

Adam Levine Continues Partnership with the "Own It" Campaign to Motivate Young Adults and Adults to Take an Active Role With Their ADHD
2/24/2014 9:00:00 AM - PR Newswire

Shire Announces FDA Approval of Manufacturing Facility for VPRIV® (Velaglucerase Alfa for Injection) Drug Substance
2/14/2014 9:00:00 AM - PR Newswire

Shire Delivers Double Digit Product Sales Growth and 23% Increase in Non GAAP Earnings per ADS
2/13/2014 8:42:00 AM - PR Newswire

Chief Financial Officer Graham Hetherington to Step Down
2/13/2014 7:32:00 AM - PR Newswire

Shire Reports Top-line Results from Two Phase 3 Studies for Vyvanse® (lisdexamfetamine dimesylate) Capsules (CII) as an Adjunctive Treatment for Adults with Major Depressive Disorder
2/6/2014 4:30:00 PM - PR Newswire

Historical Income Statements Recast for DERMAGRAFT Discontinued Operations
2/4/2014 2:00:00 AM - PR Newswire

ViroPharma Announces Tender Offer for its 2.00% Convertible Senior Notes Due 2017
1/24/2014 3:16:00 PM - PR Newswire

Shire Successfully Completes Tender Offer for ViroPharma
1/24/2014 7:51:00 AM - PR Newswire

Susan Kilsby to Succeed Matthew Emmens as Chairman of Shire
1/23/2014 2:00:00 AM - PR Newswire